Can Antibiotics Cause Nerve Damage? What You Should Know

Certain antibiotics can damage nerves, and the risk is well-documented enough that the FDA has issued specific warnings about it. Fluoroquinolones, one of the most widely prescribed antibiotic classes, carry a label warning for permanent peripheral neuropathy. They are not the only culprits. Metronidazole, nitrofurantoin, linezolid, aminoglycosides, and polymyxins have all been linked to nerve injury through different mechanisms, and the picture is more complex than most patients realize when they pick up a prescription.

Fluoroquinolones and the FDA Warning

Fluoroquinolones are the antibiotics most strongly associated with nerve damage in the public conversation, and for good reason. This class includes drugs like ciprofloxacin, levofloxacin, and moxifloxacin, prescribed for everything from urinary tract infections to pneumonia. In August 2013, the FDA updated its warning labels for fluoroquinolones to include the risk of permanent peripheral neuropathy, meaning nerve damage that does not go away after you stop the drug.¹ That word “permanent” is what sets fluoroquinolone neuropathy apart from many other drug side effects, where stopping the medication resolves the problem.

A large study published in JAMA Neurology found that people currently taking oral fluoroquinolones had roughly a 47% higher rate of peripheral neuropathy compared to periods when they were not taking the drugs. Risk increased by about 3% with each additional day of treatment, and this elevated risk persisted for up to six months after the course ended.² In one published case, a 62-year-old man developed generalized sensory disturbances just four days after starting ciprofloxacin for a urinary infection, and nerve testing revealed severe damage to both motor and sensory nerve fibers.³

Fluoroquinolone-associated disability can also extend beyond the nerves. A case series of four previously healthy adults documented a progression of symptoms that continued even after they stopped taking the drugs, evolving into a disabling combination of tendon problems, muscle weakness, peripheral neuropathy, autonomic dysfunction, sleep disruption, and cognitive and psychiatric changes.⁴ This cluster of effects is sometimes referred to informally as “floxing” by patients who have experienced it, though that is not a formal medical term.

Metronidazole and the Brain

Metronidazole is a workhorse antibiotic used for anaerobic bacterial infections, parasites, and conditions like Clostridioides difficile colitis. It can cause peripheral neuropathy, but what catches many people off guard is that it can also affect the central nervous system. A condition called metronidazole-induced encephalopathy can produce unsteady gait, slurred speech, seizures, and confusion, and these effects can occur with both short-term and prolonged use.⁵

One published case described a middle-aged man treated with high-dose metronidazole for a liver abscess. After nearly two months on the drug at 2.4 grams per day, he developed slurred speech, difficulty walking, and burning numbness in his limbs. His total cumulative dose reached about 140 grams before the neurological problems appeared.⁶ The risk with metronidazole is most associated with high doses and extended courses, which is why clinicians try to limit the duration when possible. Unlike fluoroquinolones, metronidazole-related nerve and brain symptoms often improve after stopping the drug, though not always completely.

Nitrofurantoin and Kidney Function

Nitrofurantoin is commonly prescribed for urinary tract infections, and many people take it without issue. But it carries a distinct nerve damage risk tied to how well your kidneys work. Because nitrofurantoin is cleared through the kidneys, impaired kidney function allows the drug to build up in the blood to toxic levels. At the same time, the drug’s concentration in urine drops below what’s needed to fight the infection, meaning you get more toxicity with less benefit.⁷

The peripheral neuropathy nitrofurantoin causes can be severe and irreversible. It can also affect the optic nerve.⁸ This is one of the clearest examples of why kidney function matters when choosing an antibiotic. If you have reduced kidney function, your doctor should either avoid nitrofurantoin altogether or monitor you very carefully. Many prescribing guidelines recommend against it when kidney function falls below a certain threshold for exactly this reason.

Linezolid, Aminoglycosides, and Polymyxins

Several other antibiotic classes carry nerve-related risks, often in the context of serious infections where treatment options are limited.

Linezolid is used for resistant gram-positive infections, including MRSA. Long-term use can cause mitochondrial toxicity that manifests as both peripheral neuropathy and optic neuropathy, a form of damage to the nerves that carry visual information from your eyes to your brain.⁹ This makes eye exams an important part of monitoring during extended linezolid treatment.

Aminoglycosides, such as gentamicin, tobramycin, and amikacin, primarily damage a very specific type of nerve: the auditory and vestibular nerves involved in hearing and balance. This is called ototoxicity. Genetic factors play a real role in who is vulnerable. Certain mutations in mitochondrial DNA, particularly in a gene called 12S rRNA, make some people far more susceptible to hearing loss from aminoglycosides.¹⁰ A person carrying one of these mutations might suffer permanent hearing damage from a dose that would be perfectly safe for someone without the mutation. Genetic screening before aminoglycoside use is sometimes performed, especially in settings where the drugs will be used for extended periods.

Polymyxins, including polymyxin B and colistin, are often drugs of last resort for highly drug-resistant infections. Neurotoxicity is a recognized side effect. In one case, a patient developed numbness and tingling in her hands, face, and head shortly after a polymyxin B infusion was started.¹¹ Because these drugs are reserved for life-threatening infections where nothing else works, patients and doctors typically accept the neurotoxicity risk as a trade-off.

Why Antibiotics Can Harm Your Nerves

The fact that drugs designed to kill bacteria can also damage human nerve cells seems paradoxical until you consider the evolutionary backstory. Mitochondria, the energy-producing structures inside your cells, descended from ancient bacteria billions of years ago. They still carry their own small set of DNA and have protein-building machinery that looks a lot like what modern bacteria use.¹² Some antibiotics that target bacterial protein synthesis or metabolic pathways can inadvertently interact with mitochondria for precisely this reason.¹³

Nerve cells are especially vulnerable because they are metabolically demanding. They need a constant, heavy supply of energy to function. When mitochondria are impaired by an antibiotic, nerve cells are among the first to suffer. This helps explain why the damage often shows up at the ends of the longest nerves first, the ones running to your feet and hands, where the energy supply chain is most stretched. It also explains why linezolid, which directly disrupts mitochondrial protein synthesis, can damage both peripheral nerves and the optic nerve during extended use.¹⁴

Mitochondrial toxicity is not the only mechanism at work. Fluoroquinolones, for instance, appear to damage nerves through additional pathways that researchers are still working to pin down, including possible effects on ion channels and direct toxicity to nerve fibers. Metronidazole’s neurotoxicity involves accumulation of the drug or its metabolites in neural tissue over time. The shared thread is that several common antibiotics can cross into territory where they harm human cells, particularly the energy-hungry cells of the nervous system.

Who Is Most at Risk

Not everyone who takes a fluoroquinolone or metronidazole will develop nerve problems. Several factors shift the risk.

Diabetes: People with diabetes already face a higher background risk of peripheral neuropathy. Fluoroquinolone use raises that risk further.¹⁵
Kidney impairment: Reduced kidney function raises blood levels of drugs like nitrofurantoin, tipping them from therapeutic into toxic territory.⁷
Duration of treatment: Longer courses carry higher risk. With fluoroquinolones, each additional day of treatment raises the probability of neuropathy by a small but cumulative amount.²
Cumulative dose: Metronidazole encephalopathy and neuropathy are most closely linked to high cumulative doses, as illustrated by the case of 140 grams total exposure described earlier.⁶
Genetic susceptibility: For aminoglycosides, specific mitochondrial DNA mutations dramatically increase the risk of permanent hearing damage.¹⁰
Age and existing neuropathy: Older adults and people who already have neuropathy from other causes are more susceptible to additional drug-induced nerve injury.

A frustrating aspect of antibiotic-related neuropathy is that some of these risk factors are invisible. You may not know you carry a mitochondrial DNA variant that makes you sensitive to aminoglycosides. You may not know your kidney function has declined enough to change the safety profile of nitrofurantoin. This is why blood tests to check kidney function before prescribing certain antibiotics are standard practice, not optional extras.

What the Symptoms Feel Like

Antibiotic-induced nerve damage typically starts in the feet and hands, following the pattern of most peripheral neuropathies. The earliest signs are often sensory: tingling, numbness, burning, or a “pins and needles” feeling. Some people describe it as feeling like they are wearing gloves or socks when they are not. With polymyxins, the tingling can appear in the face and head as well.¹¹

If the damage progresses, motor nerves can be affected too, leading to weakness. In severe cases like the ciprofloxacin-induced neuropathy described earlier, the damage extended to motor nerve fibers throughout the body.³ Autonomic nerves, the ones controlling things like heart rate, blood pressure, digestion, and sweating, can also be involved. Some fluoroquinolone-affected patients have reported autonomic dysfunction alongside the more typical sensory symptoms.⁴

The onset can be rapid or gradual depending on the drug. Fluoroquinolone neuropathy can appear within days of starting the medication. Metronidazole neuropathy tends to build over weeks to months of continued use. With nitrofurantoin, symptoms may develop insidiously during a long course, particularly if kidney function is compromised. Recognizing the timing matters because the earlier the drug is stopped, the better the odds of at least partial recovery.

Recovery and What Happens After You Stop

The prognosis for antibiotic-induced neuropathy varies widely by drug and by individual. With metronidazole, stopping the drug usually leads to improvement, sometimes substantial improvement, though complete resolution is not guaranteed. Many of the brain-related symptoms of metronidazole toxicity are considered reversible with early recognition.¹⁶

Fluoroquinolone neuropathy is more unpredictable. The FDA warning specifically notes the possibility of permanence, and some patients report symptoms that persist for months or years after stopping the drug. In the JAMA Neurology study, the increased risk of neuropathy lingered for up to six months after the fluoroquinolone course ended, suggesting the damage may continue evolving even after exposure stops.² Nitrofurantoin neuropathy can also be irreversible, particularly when diagnosis is delayed.⁸

There is no specific antidote for antibiotic-induced neuropathy. The primary treatment is to stop the offending drug as soon as the problem is recognized. Beyond that, management is symptomatic: medications for neuropathic pain, physical therapy for weakness, and time. For aminoglycoside ototoxicity, hearing aids or cochlear implants may be considered if hearing loss is permanent.

Practical Steps If You Are Prescribed These Antibiotics

Knowing the risk does not mean you should refuse antibiotics. Bacterial infections can be life-threatening, and the benefits of treatment typically outweigh the risks for most people. The goal is informed use rather than blanket avoidance. A few things are worth keeping in mind.

If you are prescribed a fluoroquinolone for a relatively minor infection like an uncomplicated urinary tract infection or mild sinusitis, it is reasonable to ask your doctor whether a narrower-spectrum antibiotic would work instead. In 2016, the FDA strengthened its recommendation that fluoroquinolones should be reserved for conditions where no other treatment option is suitable, precisely because of risks including neuropathy and tendon damage. For serious infections like complicated pneumonia or certain bone infections, a fluoroquinolone may genuinely be the best choice, and the risk-benefit calculation shifts.

If you are taking metronidazole, paying attention to new neurological symptoms is important, especially during courses lasting longer than a couple of weeks. Tingling in the extremities, unsteadiness while walking, or any change in speech clarity should prompt a call to your prescriber rather than a wait-and-see approach.

For nitrofurantoin, knowing your kidney function beforehand is the key protective step. If your doctor has not checked it recently and you are older or have conditions that affect the kidneys, asking about it before filling the prescription is worthwhile.

Aminoglycoside Ototoxicity as a Special Case

Hearing and balance damage from aminoglycosides deserves a separate mention because it does not look like a classic neuropathy to the person experiencing it. You will not feel tingling in your feet. Instead, you might notice ringing in the ears, difficulty hearing high-pitched sounds, or a sense that the room is tilting or spinning. The damage targets the hair cells in the inner ear and the vestibular nerve, which are exquisitely sensitive to aminoglycoside toxicity.¹⁰

This form of nerve damage is generally dose-dependent and irreversible once it occurs. In clinical practice, aminoglycoside blood levels are monitored during treatment to keep them within a safe window. Some hospitals have started offering genetic screening for the mitochondrial DNA mutations known to cause extreme sensitivity, particularly for newborns who may need aminoglycosides in the neonatal intensive care unit. The idea is simple: if you carry one of these mutations, an alternative antibiotic can be chosen before any damage is done. This kind of pharmacogenomic screening is still not routine everywhere, but it represents a shift toward preventing these injuries rather than only reacting to them.

1
PubMed Central. Permanent Peripheral Neuropathy: A Case Report on a Rare but Serious Debilitating Side-Effect of Fluoroquinolone Administration
2
PubMed Central. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy
3
PubMed Central. Severe Acute Axonal Neuropathy Induced by Ciprofloxacin: A Case Report
4
PubMed Central. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
5
PubMed Central. Clinical and Neuroradiological Spectrum of Metronidazole Induced Encephalopathy: Our Experience and the Review of Literature
6
BMJ Case Reports. Metronidazole-induced encephalopathy and polyneuropathy
7
JAMA Neurology. Peripheral Nerve Toxic Effects of Nitrofurantoin
8
Medsafe. Spotlight on nitrofurantoin
9
Retinal Cases and Brief Reports. Linezolid-Induced Mitochondrial Toxicity Presenting as Retinal Nerve Fiber Layer Microcysts and Optic and Peripheral Neuropathy in a Patient with Chronic Granulomatous Disease
10
PubMed Central. Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides
11
PubMed Central. Polymyxin B-related neurotoxicity: a brief case report
12
PubMed. Side effects of antibiotics during bacterial infection: mitochondria, the main target in host cell
13
PubMed. Side effects of antibiotics and perturbations of mitochondria functions
14
PubMed Central. Mitochondrial Toxicity of Azithromycin Results in Aerobic Glycolysis and DNA Damage of Human Mammary Epithelia and Fibroblasts
15
PubMed Central. The Effect of Antibiotics on the Nervous System: Importance for Anesthesiology and Intensive Care
16
PubMed Central. Neurotoxic effects associated with antibiotic use: management considerations